Pharmaceutical equipment companies have disclosed the performance forecast of the first three quarters, how is the performance?

[industry trends of pharmaceutical network] in the fourth quarter, pharmaceutical equipment enterprises successively disclosed the performance forecast of the first three quarters It is understood that among pharmaceutical equipment enterprises that have disclosed the performance forecast of the first three quarters, the results are mixed Truking Technology: the net profit decreased by 70% - 60% year on year Truking technology released the performance forecast for the first three quarters of 2019 on October 15 It is estimated that the net profit of the company from January to September 2019 will be 19.59 million yuan to 26.11 million yuan, compared with 65.29 million yuan in the same period of last year, down by 70% - 60% year on year According to the company, in the first three quarters of 2019, the company's operating performance declined in the same direction as that of the same period of last year The main reasons for the change in performance are: during the reporting period, the company increased its R & D investment in new products and new technologies, and the R & D expenses increased by 30% compared with that of the same period of last year; in addition, the labor cost increased, and the salary cost increased significantly compared with that of the same period of last year, resulting in a decrease in net profit compared with that of the same At the same time, during the reporting period, the company continued to provide the overall solution of medical equipment and EPC of the whole pharmaceutical plant project to the company and all members of the board of directors to ensure that the content of information disclosure is true, accurate and complete, without false records, misleading statements or major omissions With the deepening of building smart pharmaceutical factories, sufficient orders in hand, and the main business income continued to grow compared with the same period last year Dongfulong: the net profit decreased by 0% - 30% year on year On October 11, dongfulong issued the performance forecast for the first three quarters of 2019 The net profit attributable to the shareholders of the listed company was about 46.0173 million yuan - 65.739 million yuan, down 0% - 30% year on year The company said that during the reporting period, focusing on the development strategy of "systematization and internationalization", the company continued to pay attention to the development of domestic and foreign pharmaceutical industry and market dynamics, optimized the operation mechanism and internal coordination of the R & D management center, fully mobilized the innovation vitality of the R & D system, broke through the technical difficulties and met the global market demand At the same time, during the reporting period, the company's labor cost increased compared with the same period of last year, and exchange earnings decreased compared with the same period of last year Qianshan Pharmaceutical Machinery Co., Ltd.: the net profit decreased by 18.58% - 17.34% year on year It is estimated that from January 1, 2019 to September 30, 2019, the net profit loss attributable to shareholders of the listed company is 479-474 million yuan, and the net profit attributable to shareholders of the listed company decreased by 18.58% - 17.34% year on year According to the company, the main reasons are: affected by the debt crisis and asset constraints during the reporting period, the production and sales of pharmaceutical machinery declined, with operating revenue down 15.82%; and financial expenses increased year on year Argot Technology: the net profit increased by 0% to 15% year on year Argot technology announced recently that it is expected that from January 1, 2019 to September 30, 2019, the net profit attributable to shareholders of listed companies will be about 123 million yuan to 143 million yuan, up 0% to 15% year on year It is understood that in the first three quarters of 2019, the newly signed single volume of Chengdu sub optoelectronic Co., Ltd., a holding subsidiary of the company, continued to increase significantly It is estimated that the net profit of Chengdu sub optoelectronic Co., Ltd in the first three quarters of 2019 will be 145 million yuan to 155 million yuan, an increase of 70.95% - 82.74% year on year New laiyingcai: the net profit increased by 32.29% - 50.33% year on year The results of the first three quarters of 2019 released by new laiyingcai show that from January 1, 2019 to September 30, 2019, the net profit attributable to shareholders of listed companies is about 44 million – 50 million yuan, up 32.29% - 50.33% year on year During the reporting period, the rapid growth of the company's main business led to the increase of the company's operating profit; benefited from the acquisition of Shandong Bihai packaging materials Co., Ltd in 2018, the company's performance achieved a significant increase Canaan Technology: the net profit increased by 21.75% - 33.12% year on year According to Canaan technology's performance forecast for the first three quarters of 2019, from January 1, 2019 to September 30, 2019, the net profit attributable to shareholders of listed companies was 32.222 million yuan - 35.2321 million yuan, an increase of 21.75% - 33.12% over the same period of last year According to the company, the reason for the performance change is that during the reporting period, the company continued to improve the management and operation platform, actively promoted endogenous growth and extension development, and gradually implemented the "overall solution provider of solid preparation intelligent factory" and the strategic layout of large health industry in strict accordance with the formulated development plan and business objectives   At the same time, during the reporting period, the company continued to increase the development of new markets and investment in research and development of new products, strengthen the construction of brand effect and marketing network channels, and continue to promote collaborative management, quality improvement and efficiency improvement; among them, the operating revenue of the company's biological preparation water equipment business and intelligent material flow business increased steadily, and other business units carried out steadily, resulting in the company's operation Business income and net profit kept growing.